FDA Clearance Tracker · P930014-S132
AcrySof Posterior Chamber Intraocular Lens
Last checked: Nov 20, 2026Latest source record: Feb 18, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 18, 2021
Approved
Time to decision
265 days
Received May 29, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P930014-S132
- Device name
- AcrySof Posterior Chamber Intraocular Lens
- Applicant
- Alcon Laboratories, Inc.
- Applicant location
- Fort Worth, TX
- Received
- May 29, 2020
- Decided
- Feb 18, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P930014
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for a contract sterilization site located at Synergy Health Sterilisation UK Ltd., Unit 1, Alpha Court, Capitol Park, Thorne, Doncaster DN8 5TZ United Kingdom.
Source documents
Other decisions for Alcon Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.